Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 13, 2026, 11:35 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1705–1728 of 2,513 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: RAPID Clear all

Conditions: Menopause
Interventions: Estradiol withdrawal, Fragmented sleep; Drug · Other
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 41 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2022
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Alcohol Consumption, Sexual Risk Behaviors
Interventions: Counseling intervention with rapid HIV testing; Behavioral
Lead sponsor: Yale University; Other
Eligibility: 18 Years to 40 Years
Enrollment: 85 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Sensory Disorders
Interventions: High pulsed magnetic fields; Device
Lead sponsor: Weinberg Medical Physics LLC; Industry
Eligibility: 18 Years and older
Enrollment: 26 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011
U.S. locations: 1
States / cities: Freeville, New York

Conditions: Major Depressive Disorder
Interventions: aTMS utilizing the MagVenture TMS device; Other
Lead sponsor: University of Minnesota; Other
Eligibility: 18 Years to 70 Years
Enrollment: 11 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Lung Cancer, Lung Cancer Metastatic, Brain Metastases, Non Small Cell Lung Cancer
Interventions: [18F]-αvβ6-BP; Drug
Lead sponsor: University of California, Davis; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Sacramento, California

Conditions: Acute Ischemic Stroke
Interventions: C-Arm Cone Beam Computed Tomography; Diagnostic Test
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years to 99 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Mycobacterium Abscessus Lung Disease, Rapidly Growing Mycobacterial Lung Disease
Interventions: Tigecycline; Drug
Lead sponsor: The University of Texas Health Science Center at Tyler; Other
Eligibility: 10 Years and older
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2010
U.S. locations: 1
States / cities: Tyler, Texas

Conditions: Kidney Diseases, Renal Insufficiency, Chronic, Acute Kidney Injury, Urologic Diseases, Renal Insufficiency
Interventions: VFI, Iohexol; Device
Lead sponsor: FAST BioMedical; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 32 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017
U.S. locations: 2
States / cities: Birmingham, Alabama • San Antonio, Texas

Conditions: Hypertension
Interventions: Enhanced External Counterpulsation; Device
Lead sponsor: Albert Einstein Healthcare Network; Other
Eligibility: 18 Years to 80 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: COVID-19 Virus Disease
Interventions: Not listed
Lead sponsor: National Institute on Minority Health and Health Disparities (NIMHD); NIH
Eligibility: 18 Years to 65 Years
Enrollment: 464 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Keloid Scar
Interventions: Soliton's Acoustic Scar Reduction (SAR); Device
Lead sponsor: Soliton; Industry
Eligibility: 18 Years and older
Enrollment: 9 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Scottsdale, Arizona

Conditions: Major Depressive Disorder
Interventions: Transcranial Magnetic Stimulation; Device
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years to 50 Years
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Peripheral Arterial Disease, Intermittent Claudication
Interventions: Home-based leg heat therapy; Device
Lead sponsor: Purdue University; Other
Eligibility: 60 Years and older
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: West Lafayette, Indiana

Conditions: Diagnostic Test, Routine, Coronavirus, Diagnoses Disease, Rapid Coronavirus Test
Interventions: COVID Detect; Diagnostic Test
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years and older
Enrollment: 326 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Urinary Tract Infections, Bladder, Neurogenic
Interventions: Not listed
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 338 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2011
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Type 1 Diabetes Mellitus
Interventions: Insulin glargine, 300 U/ml, Insulin degludec, 100U/ml, Background therapy: Rapid acting insulin analogs; Drug
Lead sponsor: Sanofi; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 343 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Type 2 Diabetes Mellitus
Interventions: LY900014, Insulin Lispro, Insulin Glargine, Insulin Degludec, Metformin, SGLT2 inhibitor; Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 18 Years and older
Enrollment: 933 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 32
States / cities: Fresno, California • La Mesa, California • Lancaster, California + 26 more

Conditions: Diabetic Foot Ulcer, Diabetes Mellitus, Wound
Interventions: Conventional bacterial culture, Rapid diagnostic group using mNGS technology; Diagnostic Test · Device
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years and older
Enrollment: 44 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 2
States / cities: Ann Arbor, Michigan

Conditions: SARS (Severe Acute Respiratory Syndrome), Covid19
Interventions: The Pine Trees Health Test System; Diagnostic Test
Lead sponsor: Pine Trees, Inc.; Industry
Eligibility: 6 Years and older
Enrollment: 195 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021
U.S. locations: 3
States / cities: Spring Hill, Florida • Statesville, North Carolina • Redmond, Washington

Conditions: Cardiac Arrest
Interventions: Protocol for rapid FiO2 optimization; Other
Lead sponsor: Cooper Norcross Health; Other
Eligibility: 18 Years and older
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 5
States / cities: Indianapolis, Indiana • Boston, Massachusetts • Jackson, Mississippi + 2 more

Conditions: Suicidal Ideation
Interventions: Ketamine Injectable Solution, Placebo Injection, Crisis Response Plan, Safety Planning; Drug · Other · Behavioral
Lead sponsor: The University of Texas Health Science Center at San Antonio; Other
Eligibility: 18 Years to 70 Years
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 2
States / cities: Fort Hood, Texas • San Antonio, Texas

Conditions: Arterial Stiffness in Youth With Type 1 Diabetes
Interventions: Pre-meal bolus, No meal bolus; Drug
Lead sponsor: University of Florida; Other
Eligibility: 8 Years to 21 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Infectious Gastroenteritis
Interventions: FilmArray™ Gastrointestinal (GI) Panel; Device
Lead sponsor: BioFire Diagnostics, LLC; Industry
Eligibility: Up to 18 Years
Enrollment: 1,545 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 5
States / cities: Los Angeles, California • Kansas City, Missouri • Columbus, Ohio + 2 more

Conditions: PROM
Interventions: Use of Rapid Immunoassay Tests for the Detection of PROM; Device
Lead sponsor: Clinical Innovations, LLC; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 324 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 3
States / cities: Newark, Delaware • Camden, New Jersey • Salt Lake City, Utah

Search by objective public record fields.

Menopausal Sleep Fragmentation and Body Fat Gain

HIV Testing and Brief Alcohol Intervention for Young Drinkers in the Emergency Department

Sensory Effects of Rapidly-Changing Magnetic Fields

Feasibility Pilot of Accelerated Stimulation With TMS for Treatment of Major Depressive Disorder (FAST-MDD)

Fluorine-18-AlphaVBeta6-Binding Peptide Positron Emission Tomography in Metastatic Non-Small Cell Lung Cancer

C-arm Cone Beam CT Perfusion Guided Cerebrovascular Interventions

Tigecycline for Treatment of Rapidly Growing Mycobacteria

The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of FAST PV and mGFR Technology™

Role of Enhanced External Counterpulsation (EECP) Therapy in Patients With Resistant Hypertension

Natural History Study of COVID-19 Using Digital Wearables

Proof of Concept (POC) Study of the Soliton's Acoustic Scar Reduction (ASR) Treatment for the Treatment of Keloid Scar

Repetitive Transcranial Magnetic Stimulation for Treating Depression: A Functional Magnetic Resonance Imaging Study

A New Heat Therapy Device for Home-based Leg Heating in Patients With Lower-extremity Peripheral Artery Disease

COVID-19 Testing Pilot Study

A Biochip for Rapid Diagnosis of Complicated Urinary Tract Infection

Comparison of Glucose Values and Variability Between TOUJEO and TRESIBA During Continuous Glucose Monitoring in Type 1 Diabetes Patients

A Study of LY900014 Compared to Insulin Lispro in Participants With Type 2 Diabetes

Diabetic Foot Ulcer (DFU) Rapid Pathogen Identification

A Clinical Evaluation of Pine Trees Health Test System Including the Pine Trees Health Reader and COVID-19 Test for Point-of-Care

Reoxygenation After Cardiac Arrest II (REOX II Study)

Alleviating Suicidality by Combining Psychotherapy and IM Ketamine for Rapid Treatment in the Emergency Department

Arterial Stiffness in Type I Diabetes Mellitus

Implementation of a Molecular Diagnostic for Pediatric Acute Gastroenteritis: The FilmArray GI Panel IMPACT Study

Efficacy Study of Rapid Immunoassay Diagnostic Test Utilizing PP12 and AFP, ROM Plus